Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

2012858 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Pharmacology and Experimental Therapeutics

Volume 343, Issue 2, pp. 342-350

Field-Weighted Citation Impact: 28.77